Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations
Clinical trial NCT05664919 · UNKNOWN
Trial details
- NCT number
- NCT05664919
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-30
- Primary completion
- 2022-12-31
- Enrollment
- 7000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.